Cardiovascular Risks

1

Review clinical trials related to Cardiovascular Risks. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

Evaluation of Cardiovascular Risk Among the Participants of the ESC Congress 2026

The European Society of Cardiology (ESC) is dedicated to promoting cardiovascular (CV) health and minimizing the occurrence of cardiovascular diseases throughout Europe. As a founding member of the European Alliance for Cardiovascular Health (EACH), the ESC is advocating for European and National Cardiovascular Health Plans which would include a cardiovascular and diabetes health check as part of a screening process for citizens. In line with this call for public health diagnosis of CV health, the ESC is committed to raising awareness on the need for actions and proposes to offer complimentary tests to delegates at ESC Congress 2026 from 28-31 August 2026 in Munich, Germany. The primary objective of the study is to screen the CV risk among the ESC Annual Congress 2026 attendees with a focus on healthcare professionals (HCP) and to stratify by primary or secondary prevention.

Participants needed: 1,300
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: European Society of CardiologyUpdated: Aug 21, 2026
Eligibility criteria

All attendees including healthcare professionals (doctors, nurses, etc.) attendi... [+2]

Subjects not willing to provide his/her consent to participate in the study. [+1]